11 newly cleared indications, combined with three existing ones, introduce an AI safety net for crowded Emergency Departments and imaging backlogs
NEW YORK, Jan. 21, 2026 /PRNewswire/ — Aidoc, a trailblazer in clinical AI, has made headlines with its latest announcement regarding the U.S. Food and Drug Administration (FDA) clearance of the healthcare industry’s first comprehensive AI triage solution. This innovation is a game-changer, particularly at a time when Emergency Departments (EDs) are grappling with increased patient volumes and burgeoning imaging backlogs. The new solution harnesses Aidoc’s proprietary AI foundation model, known as CARE™, bringing together 11 newly cleared indications along with three existing ones into a single workflow designed to expedite the identification of critical findings, ultimately improving patient flow during peak clinical demand.
The challenges facing Emergency Departments today are significant. Patient numbers continue to rise, and imaging backlogs exacerbate delays in diagnosis and treatment. Traditionally, imaging orders are processed on a first-in, first-out basis, which can lead to critical findings waiting in line for extended periods. The comprehensive triage capability focused on abdomen CT imaging acts as a safety net, surfacing acute findings much earlier, thus facilitating timely clinical decisions and enhancing patient care.
This innovation is not limited to EDs; it also extends to outpatient settings. Patients undergoing routine exams might have concerning results that linger in backlogs for too long. Aidoc’s system significantly reduces the risk to patient safety by flagging these critical findings promptly, leading to faster follow-up and intervention when needed. It’s a proactive approach aimed at minimizing risks associated with delayed diagnoses.
The recent FDA clearance is noteworthy not just for its breadth but also for the rigorous standards it meets. Aidoc has achieved a remarkable reduction in false alerts—about tenfold compared to traditional, single-condition AI solutions. According to FDA-reviewed pivotal studies, the 11 new indications demonstrate a mean sensitivity of 97% (with peak performances hitting 98.5%) and a mean specificity of 98% (with some indications soaring up to 99.7%). These statistics underscore the safety, quality, and reliability needed for real-world clinical implementation.
Dr. Heidi Beilis, Chief Medical Officer of Diagnostics at WellSpan Health, highlights the significance of this development: “The ability to bring key acute conditions together into a single workflow is a fundamental shift in how radiology departments operate.” She points out that while many facilities have adopted various AI tools, this comprehensive triage solution directly addresses core challenges—streamlining workflow, accelerating diagnosis, and ultimately improving patient outcomes.
At the heart of Aidoc’s innovation is its aiOS™, an enterprise AI operating system that ensures sustained AI performance and governance at a scale. This system allows health systems to deploy and manage multi-condition clinical AI without overhauling their existing infrastructure. With over 100 million patient cases analyzed to date, aiOS stands out as the most widely deployed clinical AI platform in the healthcare sector.
Elad Walach, CEO and co-founder of Aidoc, expresses excitement about the potential of AI within healthcare: “Health systems are increasingly looking to AI to improve access and tackle their most pressing priorities.” He emphasizes that while breadth of indications is crucial, ensuring safety and quality is paramount. The recent FDA clearance—combining unprecedented breadth with accuracy—marks a pivotal moment for the role of clinical AI in healthcare, and Aidoc is eager to work alongside physicians in elevating patient care globally.
Aidoc’s future plans involve expanding the CARE solution roadmap to encompass all CT and X-ray workflows within the next 18 months. They are also in the process of developing added functionalities, including automated draft report generation, which drives towards comprehensive end-to-end clinical AI workflows.
For more in-depth information, you can visit the comprehensive abdomen CT triage website at https://www.aidoc.com/comprehensive-abdomen-ct-triage.
About Aidoc
Aidoc is recognized as a pioneering leader in clinical AI, boasting the largest portfolio of FDA-cleared computer-aided detection (CAD) solutions available today. Their technologies support clinical decision-making for over 60 million patients annually, enhancing efficiency, reducing cognitive workload, and improving healthcare delivery across imaging and clinical data realms.
By integrating seamlessly into clinician workflows at the point of care, Aidoc’s solutions help prioritize case management and empower healthcare professionals to make well-informed decisions confidently. With a presence in more than 1,600 medical centers worldwide, Aidoc continues to support health systems in responsibly scaling clinical AI capabilities.
Media Contact
Sarah Small
[email protected]
1 (929) 255 1449
Logo: https://mma.prnewswire.com/media/2831678/5728163/Aidoc_Always_On_AI_Logo.jpg
SOURCE Aidoc
